From: A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Reason for first admissiona | IC43 100 μg with adj (N = 104) Number (%) | IC43 100 μg w/o adj (N = 98) Number (%) | IC43 200 μg with adj (N = 101) Number (%) | Placebo (N = 98) Number (%) | Total (N = 401) Number (%) |
---|---|---|---|---|---|
Medicalb | 82 (78.8) | 75 (76.5) | 80 (79.2) | 74 (75.5) | 311 (77.6) |
Surgical | 8 (7.7) | 4 (4.1) | 9 (8.9) | 11 (11.2) | 32 (8.0) |
Traumatic | 14 (13.5) | 19 (19.4) | 12 (11.9) | 12 (12.2) | 57 (14.2) |
Unclassifiable | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) | 1 (0.2) |